Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
MiraVista Diagnostics operates as a CLIA + CAP certified reference laboratory specializing in the diagnosis of invasive fungal infections. The company provides validated diagnostic assays for detection of antigens and antibodies associated with major systemic mycoses. Their tests are widely used by clinicians to improve patient outcomes through early detection and monitoring of treatment response. They have published clinical updates on pulmonary histoplasmosis and participate actively in scientific meetings related to infectious diseases. The veterinary division offers similar testing for animal health applications.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on MiraVista Diagnostics.